What is PF/ILD: Disease pathways & treatments
In this video, Dr Chris Zappala (Respiratory & Sleep Specialist) provides an in-depth overview of Pulmonary Fibrosis (PF) and Interstitial Lung Disease (ILD). He explains the definitions and distinctions between PF and ILD, explores the underlying disease pathways, and discusses the treatment options available.
This session was recorded at the Consumer Information Day hosted by Lung Foundation Australia at the 2024 Australasian Rare Lung Disease Short Course (ARLDSC).
Managing challenging symptoms
Join Associate Professor Natasha Smallwood as she delves into managing challenging symptoms of Pulmonary Fibrosis (PF) and Interstitial Lung Disease (ILD). This video focuses on addressing common symptoms such as breathlessness, cough, and fatigue. Natasha offers practical strategies and insights to help you cope with the challenging aspects of PF/ILD and improve quality of life.
This session was recorded at the consumer information day hosted by Lung Foundation Australia at the 2024 Australasian Rare Lung Disease Short Course (ARLDSC).
Exercise & Pulmonary Fibrosis
In this video, Associate Professor Lissa Spencer discusses the vital role of exercise in managing Pulmonary Fibrosis (PF). She highlights the importance and benefits of incorporating exercise into daily routines and explains how pulmonary rehabilitation can help achieve this. Lissa provides valuable insights and guidance on how to safely and effectively use exercise to enhance overall health and well-being.
This session was recorded at the consumer information day hosted by Lung Foundation Australia at the 2024 Australasian Rare Lung Disease Short Course (ARLDSC).
Research & latest developments in PF: What’s on the horizon?
Join Professor Dan Chambers as he offers an insightful look into the latest research and developments in the field of Pulmonary Fibrosis (PF) and Interstitial Lung Disease (ILD). This video explores emerging therapies, recent scientific discoveries, and future directions in PF/ILD treatment and management. Through his expert perspective, Professor Chambers provides a sense of hope for the future, highlighting how these advancements could significantly improve outcomes and quality of life for people living with PF/ILD.
This session was recorded at the consumer information day hosted by Lung Foundation Australia at the 2024 Australasian Rare Lung Disease Short Course (ARLDSC).
Embracing hope: Navigating life with PF/ILD
In this session, we hear from a mixed panel of both clinicians and consumers on how they maintain hope while living with their lung condition, or what advice they provide to their patients on maintaining hope through the challenging times. This engaging discussion offers practical advice and emotional support by highlighting the importance of hope and resilience, providing valuable perspectives on managing life with PF/ILD.